Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...
Patent
1981-06-19
1982-10-12
Jiles, Henry R.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Parasitic organism or component thereof or substance...
548341, 548352, A61K 31415, C07D23381, C07D23306, C07D23320
Patent
active
043539211
ABSTRACT:
Novel 1,2-disubstituted imidazol(in)es are described herein. The compounds are generally produced by reacting a haloacylanilide with an excess of 2-substituted-imidazol(in)e. The compounds are antiarrhythmic agents.
REFERENCES:
patent: 4073923 (1978-02-01), Balasubzamanyan et al.
patent: 4287210 (1981-09-01), Eckhardt et al.
patent: 4292429 (1981-09-01), Marxer
Ikura et al., Chem. Abst. 1980, vol. 92, No. 58776y (+index pages).
Diamond Julius
Morgan, Jr. Thomas K.
Wohl Ronald A.
Bellamy Elizabeth A.
Berlex Laboratories Inc.
Harkaway N.
Jiles Henry R.
Millen I. William
LandOfFree
Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, co does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiarrythmic 1-arylcarbamoylalkyl-2-imidazoline derivatives, co will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-223472